These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38409698)

  • 1. Hub Genes Involved in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma.
    Liu B; Wang X; Wu N; Liu F; Rao H
    Curr Med Chem; 2024 Feb; ():. PubMed ID: 38409698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
    Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of differentially expressed genes and immune cell infiltration in the progression of nonalcoholic steatohepatitis (NASH) to hepatocellular carcinoma (HCC): a new exploration based on bioinformatics analysis.
    Liu Y; Yu X; Wang Y; Wu J; Feng B; Li M
    Nucleosides Nucleotides Nucleic Acids; 2024 Feb; ():1-16. PubMed ID: 38319987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of key pathways and genes in nonalcoholic fatty liver disease using bioinformatics analysis.
    Liu J; Lin B; Chen Z; Deng M; Wang Y; Wang J; Chen L; Zhang Z; Xiao X; Chen C; Song Y
    Arch Med Sci; 2020; 16(2):374-385. PubMed ID: 32190149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shared Genes and Molecular Mechanisms between Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma Established by WGCNA Analysis.
    He J; Zhang X; Chen X; Xu Z; Chen X; Xu J
    Glob Med Genet; 2023 Sep; 10(3):144-158. PubMed ID: 37501756
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioinformatics Analysis Explores Potential Hub Genes in Nonalcoholic Fatty Liver Disease.
    Wu C; Zhou Y; Wang M; Dai G; Liu X; Lai L; Tang S
    Front Genet; 2021; 12():772487. PubMed ID: 34777484
    [No Abstract]   [Full Text] [Related]  

  • 7. Key genes associated with non-alcoholic fatty liver disease and hepatocellular carcinoma with metabolic risk factors.
    Yang F; Ni B; Lian Q; Qiu X; He Y; Zhang Q; Zou X; He F; Chen W
    Front Genet; 2023; 14():1066410. PubMed ID: 36950134
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening of co-pathogenic genes of non-alcoholic fatty liver disease and hepatocellular carcinoma.
    Chen T; Zhang S; Zhou D; Lu P; Mo X; Tamrakar R; Yang X
    Front Oncol; 2022; 12():911808. PubMed ID: 36033523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma.
    Kurokawa S; Yoneda M; Ogawa Y; Honda Y; Kessoku T; Imajo K; Saito S; Nakajima A; Hotta K
    BMC Gastroenterol; 2022 Jun; 22(1):278. PubMed ID: 35655171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel biomarker genes for the prediction of post-hepatectomy survival of patients with NAFLD-related hepatocellular carcinoma.
    Song Y; Wang Y; Geng X; Wang X; He H; Qian Y; Dong Y; Fan Z; Chen S; Wen W; Wang H
    Cancer Cell Int; 2023 Nov; 23(1):269. PubMed ID: 37950277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular Carcinoma Due to Nonalcoholic Fatty Liver Disease: Current Concepts and Future Challenges.
    Ahmad MI; Khan MU; Kodali S; Shetty A; Bell SM; Victor D
    J Hepatocell Carcinoma; 2022; 9():477-496. PubMed ID: 35673598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weighted Gene Co-Expression Network Analysis of Immune Infiltration in Nonalcoholic Fatty Liver Disease.
    Wang Z; Xia Y; Pan Y; Zhang L; Tang F; Yu X; Yang Z; Wang D; Yang L; Jia J; Yuan G
    Endocr Metab Immune Disord Drug Targets; 2023; 23(9):1173-1185. PubMed ID: 36503447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of hub genes and key pathways of dietary advanced glycation end products‑induced non‑alcoholic fatty liver disease by bioinformatics analysis and animal experiments.
    Wang J; Liu H; Xie G; Cai W; Xu J
    Mol Med Rep; 2020 Feb; 21(2):685-694. PubMed ID: 31974594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential biomarkers in the fibrosis progression of nonalcoholic steatohepatitis (NASH).
    Wang Z; Zhao Z; Xia Y; Cai Z; Wang C; Shen Y; Liu R; Qin H; Jia J; Yuan G
    J Endocrinol Invest; 2022 Jul; 45(7):1379-1392. PubMed ID: 35226336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic Retinopathy as a Risk Factor Associated with the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
    Azuma S; Asahina Y; Kakinuma S; Azuma K; Miyoshi M; Inoue E; Tsunoda T; Sato A; Kaneko S; Nagata H; Kawai-Kitahata F; Murakawa M; Nitta S; Itsui Y; Tomita M; Nakagawa M; Watanabe M
    Dig Dis; 2019; 37(3):247-254. PubMed ID: 30625487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NUSAP1 Could be a Potential Target for Preventing NAFLD Progression to Liver Cancer.
    Zeng T; Chen G; Qiao X; Chen H; Sun L; Ma Q; Li N; Wang J; Dai C; Xu F
    Front Pharmacol; 2022; 13():823140. PubMed ID: 35431924
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis: HCC and Steatosis or Steatohepatitis.
    Petrelli F; Manara M; Colombo S; De Santi G; Ghidini M; Mariani M; Iaculli A; Rausa E; Rampulla V; Arru M; Viti M; Lonati V; Ghidini A; Luciani A; Facciorusso A
    Neoplasia; 2022 Aug; 30():100809. PubMed ID: 35636146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Fukusato T
    World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatic Analysis of Key Biomarkers and Infiltrating Immune Cells in Nonalcoholic Fatty Liver Disease.
    Chen G; Jiang S; Kong L; Yang T; Sun X; Xu T; Fan L; Xie Q; Zhao H
    Altern Ther Health Med; 2023 Nov; ():. PubMed ID: 37944972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease.
    Lin BZ; Lin TJ; Lin CL; Liao LY; Chang TA; Lu BJ; Chen KY
    J Chin Med Assoc; 2021 Jun; 84(6):606-613. PubMed ID: 33871391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.